If Cigna's cash incentive becomes precedent, are you prepared to quickly react if your brand is the focus for a new non-medical switching campaign?
New administration, new approach to healthcare: the old playbook isn't enough anymore. Is your pharma brand ready to optimize patient, caregiver, and HCP experiences in this evolving landscape?
Many pharma executive and marketing leaders actively monitor the pricing transparency conversation in search of the meaningful insights that can truly impact their business performance. And while much public attention has been paid to items such as “drug costs in TV commercials” and “CEO testimony before Congress,” little evidence exists
Wasn’t it exciting as a kid when one of your favorite TV shows would have a special multi-episode arc full of guest stars? Well, the same thing has been happening in the U.S. Senate this year, as the Finance Committee takes on drug pricing. They’ve held several hearings in which